Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8+ T cells via increasing intratumoral CXCL10.
Huang MY, Chen YC, Lyu WY, He XY, Ye ZH, Huang CY, He XL, Chen X, Chen X, Zhang B, Kai G, Zhang X, Li T, Huang M, Lu JJ.
Huang MY, et al. Among authors: li t.
Pharmacol Res. 2023 Dec;198:106988. doi: 10.1016/j.phrs.2023.106988. Epub 2023 Nov 19.
Pharmacol Res. 2023.
PMID: 37984507
Free article.